PTL as a natural product has been suggested to target the leukemia stem cells (LSCs) in acute myeloid leukemia (AML) (Siveen et al., 2017) via regulating ROS levels and the anti-proliferative activity of cancer cells (Kempema et al., 2015). The gene discussed is PNLIP; the disease is cancer.